Portola Pharmaceuticals SEC Filings & 10K Form (NASDAQ:PTLA)

$30.37
+0.15 (+0.50 %)
(As of 09/22/2019 02:24 PM ET)
Today's Range
$29.88
Now: $30.37
$30.72
50-Day Range
$24.37
MA: $28.98
$31.10
52-Week Range
$14.81
Now: $30.37
$37.95
Volume769,741 shs
Average Volume892,934 shs
Market Capitalization$2.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.13

SEC Filings

Portola Pharmaceuticals (NASDAQ:PTLA) SEC Filings

DateFilerForm TypeView
09/05/2019
6:06 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
6:02 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:04 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:46 PM
Portola Pharmaceuticals (Filer)
Form 424B5
08/09/2019
5:51 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:14 PM
Portola Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
4:11 PM
Portola Pharmaceuticals (Filer)
Form S-3ASR
08/07/2019
3:12 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
7:06 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:42 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:36 PM
Portola Pharmaceuticals (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:33 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:26 PM
JOHNSON JOHN (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:19 PM
FENTON DENNIS M (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:14 PM
Brege Laura (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:48 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
4:06 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
7:28 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
7:20 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
7:36 AM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:07 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
10:20 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
8:33 PM
Portola Pharmaceuticals (Filer)
Form DEFA14A
04/19/2019
8:31 PM
Portola Pharmaceuticals (Filer)
Form DEF 14A
04/16/2019
6:44 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
6:03 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
6:27 PM
HOMCY CHARLES J (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
4:11 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
8:17 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:30 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:26 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:16 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
1:48 PM
Portola Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2019
7:18 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:22 PM
Partner Fund Management, L.P. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
10:57 AM
Portola Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/14/2019
10:55 AM
Portola Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/14/2019
5:13 AM
Portola Pharmaceuticals (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
02/13/2019
11:02 AM
FMR LLC (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
3:19 PM
Flynn James E (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
1:29 PM
Portola Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2019
9:00 AM
Portola Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
6:17 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/06/2019
2:03 PM
BlackRock Inc. (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2019
5:12 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
5:09 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:56 PM
Moriarty John B (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:50 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:47 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:40 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:35 PM
Koenig Sheldon L. (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:32 PM
Koenig Sheldon L. (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/15/2019
7:14 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
7:11 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:56 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
4:46 PM
HOMCY CHARLES J (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
4:21 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
6:07 PM
HOMCY CHARLES J (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
7:15 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
4:24 PM
HOMCY CHARLES J (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
3:40 PM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:11 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2018
5:29 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
2:19 PM
Flynn James E (Filed by)
Portola Pharmaceuticals (Subject)
Form SC 13G
10/17/2018
5:45 PM
Garland J. Scott (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2018
3:38 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
7:44 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2018
7:42 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:27 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
6:18 PM
Fu Tao (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:43 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
5:35 PM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
5:13 PM
Lis William (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
5:06 PM
Fu Tao (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
5:03 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
5:00 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
6:32 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
11:22 AM
Meyer Ernie (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2018
3:02 PM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
7:15 AM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2018
2:26 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2018
2:22 PM
Brame Glenn P (Reporting)
Portola Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2018
4:01 PM
BIRD JEFFREY W (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:42 PM
Portola Pharmaceuticals (Issuer)
RENTON HOLLINGS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:37 PM
HOMCY CHARLES J (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:27 PM
Portola Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:23 PM
Portola Pharmaceuticals (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:18 PM
Lis William (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:14 PM
JOHNSON JOHN (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:00 PM
FENTON DENNIS M (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
4:56 PM
Brege Laura (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
4:22 PM
Portola Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2018
5:17 AM
Portola Pharmaceuticals (Filer)
Form DEFA14A
06/04/2018
4:12 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
7:22 PM
Lis William (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
7:06 PM
Fu Tao (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
7:04 PM
Dier Mardi (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
7:02 PM
Curnutte John T (Reporting)
Portola Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
3:45 PM
Portola Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
3:12 PM
Portola Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel